CRO’s are looking for a proven platform- so they don’t have to spend time and money to build.
Hybrid decentralized clinical trials model ideal for
Phase III and Phase IV post-marketing trials.
- Ideal for Survivability visits.
- Ideal for Outcome trials.
- Ideal for rare disease indications.
- Ideal for centralized ratings-CNS trials.
Protected view access to reporting dashboard to view patient compliance.
Clinical research sites worldwide have access to complimentary training to become certified as virtual capable.
Virtually certified sites easier/quicker hybrid study start up.